[Disorders of lipid metabolism and renal failure--what is cause, what is sequelae?].
DerFler
K
K
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000503:physiopathology* / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000503:physiopathology* / Q000628:therapy; D016030:Kidney Transplantation / Q000502:physiology; D011183:Postoperative Complications / Q000503:physiopathology / Q000628:therapy; D017035:Pravastatin / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017035:Pravastatin